4.7 Article

CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents

Journal

JOURNAL OF INFECTION
Volume 69, Issue 6, Pages 569-580

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2014.05.015

Keywords

Tuberculosis; Antigen diagnostic reagents; Aptamers; Enzyme-linked oligonucleotide assay (ELONA); CFP10-ESAT6 (CE)

Funding

  1. National Grand Program on Key Infectious Disease [2012ZX10003002-015]
  2. National Natural Science Foundation of China [31221061, 31270176, 31370197]
  3. National Outstanding Youth Foundation of China [81025008]
  4. 973 Program of China [2012CB720604]
  5. Program for Changjiang Scholars and Innovative Research Team in University [IRT1030]
  6. Hubei Province's Outstanding Medical Academic Leader Program [523-276003]
  7. Development Fund for Collaborative Innovation Center of Glycoscience of Shandong University
  8. Science and Technology Program of Wuhan [201150530141]

Ask authors/readers for more resources

The development of effective Mycobacterial antigen diagnostic reagents remains a high priority. The 6-kDa early secreted antigenic target (ESAT6) and 10-kDa culture filtrate protein (CFP10) are secreted early by virulent Mycobacterium tuberculosis (M. tb) and are not present in the non-virulent Bacillus Calmette-Guerin (BCG). In this study, we used a Systematic Evolution of Ligands by Exponential Enrichment (SELEX) technique to screen for a functional ssDNA aptamer antibody that specifically bound to ESAT6-CFP10 (CE) protein. The selected single ssDNA aptamers (CE24 and CE15) demonstrated the highest specificity and binding affinity to CFP10 (CE24: K-d = 3.75 x 10(-7) M) and ESAT6 (CE15: K-d = 1.6 x 10(-7) M). We further detected CFP10 and ESAT6 proteins in serum samples from active pulmonary tuberculosis (TB) patients, extrapulmonary TB patients and healthy donors by using an enzyme-linked oligonucleotide assay (ELONA). The results showed that the sensitivity and specificity were 100% and 94.1% (using CE24 aptamer-based ELONA) and 89.6% and 94.1% (using CE15 aptamer-based ELONA), respectively. A good correlation was observed between aptamer-based ELONA and T-SPOT TB assay. Thus, our study suggests that CE24 and CE15 have potentially broad applications as early antigen diagnostic agents not only for active pulmonary TB, extrapulmonary TB, but also possibly for latent TB infection and TB with immune-deficiency. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available